Opko Health traded at $1.35 this Thursday December 8th, decreasing $0.01 or 0.74 percent since the previous trading session. Looking back, over the last four weeks, Opko Health lost 12.90 percent. Over the last 12 months, its price fell by 65.12 percent. Looking ahead, we forecast Opko Health to be priced at 1.42 by the end of this quarter and at 1.29 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 106.92 2.11 2.01% -20.43%
Acadia Pharmaceuticals 14.63 -0.03 -0.20% -35.32%
Acorda Therapeutics 0.56 0.03 5.36% -79.17%
Agios Pharmaceuticals 28.69 0.76 2.72% -6.18%
Akebia Therapeutics 0.30 0 0% -88.24%
ALKERMES 25.48 0.21 0.83% 13.95%
Alnylam Pharmaceuticals 238.01 6.68 2.89% 38.00%
Amarin 1.20 0.03 2.56% -64.18%
Ardelyx 1.82 0.03 1.68% 15.19%
Arrowhead Research 31.56 -1.30 -3.96% -55.44%
Bluebird Bio 7.84 -0.10 -1.26% -16.42%
BioMarin Pharmaceutical 104.39 0.70 0.68% 21.92%
Bristol-Myers Squibb 79.88 -0.05 -0.06% 38.83%
Coherus Biosciences 6.83 0.19 2.86% -60.15%
Quest Diagnostics 150.50 1.50 1.01% -4.58%
Emergent BioSolutions 12.46 0.08 0.65% -68.84%
Esperion Therapeutics 6.18 -0.15 -2.37% 16.60%
Exact Sciences 45.96 0.06 0.13% -43.32%
Exelixis 16.52 0.17 1.04% -0.30%
Halozyme Therapeutics 57.85 0.11 0.19% 81.80%
Intercept Pharmaceuticals 14.70 0.25 1.73% 0.93%
Insmed 18.63 -0.30 -1.58% -30.79%
Ionis Pharmaceuticals 38.00 -0.20 -0.52% 25.50%
Ironwood Pharmaceuticals 11.80 -0.11 -0.92% 4.70%
Laboratory Of America 235.68 2.00 0.86% -16.42%
Lexicon Pharmaceuticals 2.17 0.10 4.83% -49.77%
Moderna Inc 184.70 5.70 3.18% -32.15%
Myriad Genetics 19.49 -0.12 -0.61% -22.44%
Neurocrine Biosciences 120.39 -1.12 -0.92% 47.50%
Opko Health 1.35 -0.01 -0.74% -65.12%
Puma Biotechnology 4.58 0.43 10.36% 46.33%
PTC Therapeutics 38.28 -1.13 -2.87% 6.48%
Ultragenyx Pharmaceutical 41.21 1.70 4.30% -47.50%
Seattle Genetics 125.24 5.88 4.93% -13.60%
Sarepta Therapeutics 119.34 -0.42 -0.35% 39.64%
Teva Pharmaceutical Industries 8.32 -0.13 -1.54% 0.36%
United Therapeutics 279.88 2.80 1.01% 49.64%
Vanda Pharmaceuticals 10.83 -0.01 -0.09% -31.33%

Indexes Price Day Year
US2000 1818 11.39 0.63% -18.10%

Opko Health
OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.